91Ó°ÊÓ

In hypothesis testing, the null hypothesis \(H_0\) serves as a statement of no effect or no difference. It basically represents the default or original assumption that there is no significant change or association between variables. In the context of the given study on aspirin use and breast cancer, the null hypothesis posits that there is no difference in the proportion of regular aspirin users between women with breast cancer and those without.

It's important to clarify that when we say "there is no difference," we're not suggesting equality in proportions, rather we are asserting that any observed difference occurs purely by chance. The validity of this assumption is questioned through hypothesis testing, which aims to statistically determine if the observed data provide strong enough evidence to reject the null hypothesis. This is a foundational step to ensure that we are not jumping to conclusions based on mere speculation.

While the null hypothesis establishes a baseline statement, the alternative hypothesis \(H_A\) represents the outcome researchers expect or are interested in proving through the study. It is a statement that indicates the presence of an effect or difference. In this study investigating any potential link between aspirin use and breast cancer, the alternative hypothesis claims that the proportion of aspirin users is lower among women who have breast cancer compared to those who do not.

The alternative hypothesis challenges the status quo suggested by the null hypothesis. It proposes a clear direction of difference, implying that the use of aspirin could potentially reduce the risk of developing breast cancer. This hypothesis is tested using statistical evidence collected from the study sample. If the statistical analysis deems this evidence significant, the null hypothesis can be rejected in favor of the alternative hypothesis.

Proportion comparison is a crucial aspect of this study as it involves comparing proportions of regular aspirin users between two different groups: women with and without breast cancer. It is an essential part of hypothesis testing in categorical data analysis. The study calculates two sample proportions: \(p_1\) for women with breast cancer and aspirin use, and \(p_2\) for women without breast cancer and aspirin use.

Specifically, for women with breast cancer, the proportion of regular aspirin users is calculated as \(p_1 = 301 / 1442 = 0.2086\), and for the control group without breast cancer, the proportion is given as \(p_2 = 345 / 1420 = 0.2429\). By comparing these two proportions, researchers can establish whether there is a significant difference in aspirin use between the groups.

This comparison requires the use of statistical tests, like the Z-test for proportions, which determines if the observed differences in proportions are statistically significant and not merely due to random chance.

The significance level, often denoted by \(\alpha\), is a threshold set by researchers to determine when to reject the null hypothesis. It quantifies the risk of concluding that a difference exists when there is none — essentially the rate of type I error. In this study's context, the significance level is established at 0.05, or 5%.

This means that the researchers are willing to accept a 5% chance of incorrectly rejecting the null hypothesis. In practice, if a calculated p-value is less than the significance level, the result is considered statistically significant, giving grounds to reject the null hypothesis. For example, in this study, the p-value turned out to be 0.0005, which is substantially lower than the 0.05 threshold.

This low p-value indicates strong evidence against the null hypothesis, leading to the conclusion that the proportion of aspirin users who have breast cancer is significantly lower than those without breast cancer. Choosing an appropriate significance level is crucial because it impacts the conclusions drawn from statistical tests.